Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apremilast in Erosive Hand Osteoarthritis
NCT01200472Phase 2Completed
- Sponsor
- FAU Erlangen-Nürnberg Medical Faculty
- Start
- Aug 2010
- Primary completion
- Aug 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of apremilast in erosive hand osteoarthritis (EHOA), sponsored by FAU Erlangen-Nürnberg Medical Faculty. Started Aug 2010; status: completed.
02
Drugs
apremilast
03
Conditions
erosive hand osteoarthritis (EHOA)
Beyond the preview
Go deeper on NCT01200472.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01200472.